1.0300
-0.0900
(-8.04%)
As of 1:13:31 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cost of Revenue
--
--
--
-659.4830
-178.0140
Gross Profit
--
--
--
659.4830
178.0140
Operating Expense
3,624.8930
3,887.2720
2,826.4730
2,198.0040
2,859.6150
Operating Income
-3,624.8930
-3,887.2720
-2,826.4730
-2,198.0040
-2,859.6150
Net Non Operating Interest Income Expense
-558.8200
-512.8300
-459.3120
-411.2650
-335.8810
Pretax Income
-4,183.7130
-4,400.1020
-3,285.7850
-2,609.2690
-3,195.4960
Net Income Common Stockholders
-4,183.7130
-4,400.1020
-3,285.7850
-2,609.2690
-3,195.4960
Diluted NI Available to Com Stockholders
-4,183.7130
-4,400.1020
-3,285.7850
-2,609.2690
-3,195.4960
Basic EPS
-0.07
-0.10
-0.11
-0.08
-0.11
Diluted EPS
-0.07
-0.10
-0.11
-0.08
-0.11
Basic Average Shares
52,959.8800
42,190.1720
29,785.4750
31,279.2860
28,094.5780
Diluted Average Shares
52,959.8800
42,190.1720
29,785.4750
31,279.2860
28,094.5780
Total Operating Income as Reported
-3,624.8930
-3,887.2720
-2,826.4730
-2,198.0040
-2,859.6150
Total Expenses
3,624.8930
3,887.2720
2,826.4730
2,198.0040
2,859.6150
Net Income from Continuing & Discontinued Operation
-4,183.7130
-4,400.1020
-3,285.7850
-2,609.2690
-3,195.4960
Normalized Income
-4,183.7130
-4,400.1020
-3,285.7850
-2,609.2690
-3,195.4960
Interest Income
0.5240
0.1440
0.0020
--
--
Interest Expense
559.3440
512.9740
459.3140
411.2650
335.8810
Net Interest Income
-558.8200
-512.8300
-459.3120
-411.2650
-335.8810
EBIT
-3,624.3690
-3,887.1280
-2,826.4710
-2,198.0040
-2,859.6150
EBITDA
-2,535.4450
-2,859.2020
-2,615.7450
-2,198.0040
-2,612.4560
Reconciled Cost of Revenue
--
--
--
-659.4830
-178.0140
Reconciled Depreciation
1,088.9240
1,027.9260
210.7260
--
247.1590
Net Income from Continuing Operation Net Minority Interest
-4,183.7130
-4,400.1020
-3,285.7850
-2,609.2690
-3,195.4960
Normalized EBITDA
-2,535.4450
-2,859.2020
-2,615.7450
-2,198.0040
-2,612.4560
12/31/2020 - 7/6/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GUARD.ST Guard Therapeutics International AB (publ)
21.20
-2.75%
SIMRIS-B.ST Simris Group AB (PUBL)
0.0812
-6.02%
COMBI.ST CombiGene AB (publ)
2.3400
-3.31%
CRNA.OL Circio Holding ASA
0.6940
-1.70%
CMOTEC-B.ST Scandinavian ChemoTech AB (publ)
1.1200
+1.82%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
-3.09%
QUIA.ST Quia Pharma AB (publ)
0.0082
-7.87%
2CUREX.ST 2cureX AB (publ)
0.4400
+22.22%
ULTI.OL Ultimovacs ASA
2.1850
+0.69%
NANECH.ST NanoEcho AB
0.1220
-30.05%